IMRA Research and Charts

IMRA - Imara Inc Ordinary Shares (Healthcare: Biotechnology)

Projected Earnings Date: 2023-08-07 (Delayed quote data 2025-10-29)

Last 32.00	Change ⇓ -0.84 (-2.56%)	Volume 3,740
	Open 32.00	High 33.48	Low 32.00

8EMA (Daily) 35.24	40EMA (Daily) 37.63	50EMA (Daily) 38.09	STO (Daily) 8.797	MACD Hist (Daily) -0.907
8EMA (Weekly) 35.645	40EMA (Weekly) 33.35	50EMA (Weekly) 30.84	STO (Weekly) 15.379	MACD Hist (Weekly) -0.970


Company Profile
Imara Inc is a clinical-stage biopharmaceutical company engaged in developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of haemoglobin.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.